vancomycin has been researched along with rifapentine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Gagnon, RF; Harris, A; Obst, G; Prentis, J; Richards, GK | 1 |
| Abdel, MP; Albano, M; Berry, DJ; Karau, MJ; Mandrekar, JN; Oravec, CP; Osmon, DR; Patel, R; Rivera, CG; Schmidt-Malan, SM | 1 |
1 review(s) available for vancomycin and rifapentine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for vancomycin and rifapentine
| Article | Year |
|---|---|
The activity of rifampin and analogs against Staphylococcus epidermidis biofilms in a CAPD environment model.
Topics: Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory; Rifampin; Rifamycins; Staphylococcus epidermidis; Structure-Activity Relationship; Vancomycin | 1989 |
Novel Use of Rifabutin and Rifapentine to Treat Methicillin-Resistant Staphylococcus aureus in a Rat Model of Foreign Body Osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Therapy, Combination; Foreign Bodies; Male; Methicillin-Resistant Staphylococcus aureus; Osteomyelitis; Rats; Rats, Wistar; Rifabutin; Rifampin; Staphylococcal Infections; Vancomycin | 2020 |